Dry particulate vaccine for oral administration

Details Dry particulate vaccine for oral administration Dry particulate vaccine for oral administration

1980-01-31

1981-02-17

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Lymphokine

424 35, 424 36, 424 93, A61K 3917

Patent

active

042515092

ABSTRACT:
A vaccine in the form of a dry particulate comprising a matrix formed of a protein component as a binder and sugar as a solubilizing agent and which includes an antigen in the matrix in an amount to provide for a titre in excess of 1.times.10.sup.5 units per particulate and in which the moisture content is less than 1.0% by weight and which may include an antioxidant to stabilize the vaccine, an immunostimulant to enhance the response of the vaccine and a facilitator to enhance cell entry.

REFERENCES:
patent: 2744015 (1956-05-01), Katsube
patent: 2809112 (1957-10-01), Anderson et al.
patent: 3072528 (1963-01-01), Kludas et al.
patent: 3285748 (1966-11-01), Koonz et al.
patent: 3823228 (1974-07-01), Ferris et al.
patent: 3956482 (1976-05-01), Hahn et al.
patent: 3957974 (1976-05-01), Hata

Affiliated with

Also associated with

Rating

Dry particulate vaccine for oral administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dry particulate vaccine for oral administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry particulate vaccine for oral administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2262225